Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized, placebo-controlled study of M127101 in eosinophilic chronic rhinosinusitis with nasal polyps
jRCT2061240008Phase 2Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic rhinosinusitis (CRS) comparing M127101 nebulization once daily with Placebo nebulization once daily (2 arms). Primary endpoint: Nasal Polyp Score. Started May 2024; status: completed.
02
Drugs
M127101
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on jRCT2061240008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2061240008.